Human Cyclin Dependent Kinase 4 (CDK4) ELISA Kit

The Cyclin Dependent Kinase 4 (CDK4) target is a serine/threonine kinase that partners with cyclin D1 to phosphorylate retinoblastoma protein (RB1), driving the G1 to S phase transition of the cell cycle. Dysregulated CDK4 activity is implicated in melanoma, glioblastoma, breast carcinoma, and liposarcoma, making quantitative CDK4 protein measurement valuable for oncology research, cell cycle studies, and drug discovery workflows targeting CDK4/6 inhibitors such as palbociclib.

Use this Assay Genie immunoassay with tissue homogenates and cell lysates to profile CDK4 expression across cultured cancer cell lines and primary tissue specimens. The microplate format supports batched sample processing for high-throughput screening campaigns. Reconstituted reagents should be refrigerated and protected from light to preserve activity through the stated shelf life, and standard stocks should be aliquoted to limit freeze-thaw cycles.